Authors
Latest:
Case Study: A Drug Launch into COVID HeadwindsLessons to launch by during a pandemic—or otherwise.
Latest:
How to Navigate Global Regulatory Hurdles to Successfully Launch a Medical DeviceManufacturers must navigate complex regulatory landscapes, understand diverse cultural nuances, and prioritize patient access in each region.
Latest:
A Look Back: The Life Sciences Industry in 2023 and a View for 2024In the coming year, efficiency and automation will take center stage to maximize constrained resources but balancing sensible financial management with strategic investments will be vital.
Latest:
The Role of AI in Digital TherapeuticsAI-enabled digital therapeutics have helped give new meaning to the term personalized medicine by tailoring not just the treatment itself, but the way that treatment is managed to the individual characteristics of each patient.
Latest:
Bridging the Data GapHow interoperability and clean data can harness the power of big data in pharma.
Latest:
As the Life Sciences Industry Transforms, New Risks EmergeLife sciences companies are collaborating more with technology enterprises, universities, and other groups, which is changing the landscape of the industry.
Latest:
Why Pharmaceutical Manufacturers Must Navigate Muddy Waters of ESG RequirementsRise in demand for sustainable practices forces industry to be more proactive.
Latest:
Blockchain, COVID-19 and the Pharmaceutical Supply ChainHannah Schofield and Lavan Thasarathakumar discuss what blockchain is, how it could help improve pharmaceutical supply chains, and the COVID-19 vaccine supply chain in particular, and touches on where we are already seeing blockchain technology being used in this area.
Latest:
How to Optimize ERP: Insights from Galera and Nabriva Therapeutics*** Wednesday, February 3, 2021 at 1pm EST | 12pm CST | 10am PST*** Industry leading ERP & MRP Solutions for Pharma. Join our informative Webinar with AdaptaLogix, the fastest growing NetSuite & Oracle partner, to learn more about the solutions that have been developed to meet mid-market pharma’s unmet needs. ***On demand available after final airing until Feb. 3, 2022***
Latest:
ROI and Rare Disease: Retooling the ‘Gene’ Value MachineFramework proposes three strategies designed to address the unique challenges of personalized and genetic therapies for rare diseases—and increase the probability of economic success for a new wave of potential curative treatments for these conditions.
Latest:
Why Program Management is the Key to Success for Life Science CompaniesDelivering value with enterprise program management.
Latest:
Building a Plan for Digital Transformation in Medical AffairsLeslie Rotz and Todd Parker outline four major steps in the Medical Affairs digital transformation journey.
Latest:
PREP Act Protections for COVID-19 Vaccine LiabilityHow PREP Act protections will apply to potential COVID-19 vaccine-related claims.
Latest:
Measuring Speaker Campaign EffectivenessSales and marketing effectiveness of speaker programs is often one of the least understood aspects in the industry. Yet, pharma brands spent over $12.5 billion in 2022 to engage and influence with HCP-to-HCP activities. CMS’s Open Payments data is an overlooked tool to get greater visibility and create more strategic opportunities—while also enriching compliance. This paper explores how to filter and pinpoint critical data sets using browser-based technology to gain marketing insights from this data and measure competitiveness.
Latest:
Navigating Disruption in the Metapharma EraAs the life sciences industry enters this next stage of growth, capitalizing on AI and digital transformation will be key to propelling innovation and ensuring that companies are prepared to tackle the challenges ahead.
Latest:
Purposeful Partnerships for Post-COVID EraPharma should be the ‘glue’ that bonds healthcare organizations together to solve society’s most pressing challenges.
Latest:
Creative Solutions to the Healthcare CrisisWhat can the industry do to create more equality in our healthcare system?
Latest:
An Integrated Patient Advocacy Strategy With Transparent CommunicationA roadmap for cohering patient perspectives.
Latest:
Beyond buzzwords – How to implement digital transformationThursday, November 11, 2021 at 11am, EST | 8am PST| 4pm GMT | 5pm CET If you want to transform to a secure, scalable SaaS platform with a modern, intuitive interface for complete control in configuring workflows for your ever growing list of techniques, modalities, and data types, this webinar is for you.
Latest:
mRNA Technology: First COVID-19, Now CancerHaving proved its efficacy against COVID-19, mRNA technology is positioned to combat another insidious human adversary: cancer.
Latest:
Comparing Registry and Electronic Health Record Data for Real-World Evidence Generation: Heart Failure as a Case StudyContrasting the view of heart failure patients as seen from the perspectives of two large but distinct sources of real-world data: the Veradigm Cardiology Registry and Practice Fusion
Latest:
Closing the Gaps in Pre-Approval Information Exchange to Accelerate Product Success and Patient AccessGaps remain in the pre-approval information process leave payers without all of the information they need to make the proper decisions.
Latest:
Survey Suggests Pharma Industry Still Struggling with Digital TransformationThe results say that the industry still lacks talent and skills in this area.
